Physician

Kuumba K Long, MD

According to 2025 Medicare claims, Kuumba Long, MD (NPI: 1558400291) practices ophthalmology in the Kokomo, IN market, with the plurality of this provider's patient population coming from Howard, IN. This provider's primary affiliated billing organization is MIDWEST EYE CONSULTANTS, P.C. (NPI: 1801002522; TIN: 352123280) and primary practice location at 46902-3275.

Long's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 989 traditional Medicare patients, billed 3,188 HCPCS/CPT codes, and received $631,314 in Medicare payments. The top billing code was 66982 (Complex removal of cataract with insertion of prosthetic lens). Part D data shows 132 prescription claims across 95 beneficiaries totaling $1,557 in drug costs, led by Bacitracin-Polymyxin (Bacitracin/Polymyxin B Sulfate). Open Payments data shows 6 records totaling $141. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $53,892 to $1,557. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$388K$777K2015 Medicare payment: $720,148 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $651,941 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $601,666 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $776,712 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $749,417 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $707,805 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $698,340 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $704,175 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $692,221 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $631,314 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159673,184$720,148
20168702,961$651,941
20178272,710$601,666
20188643,359$776,712
20198593,087$749,417
20208693,186$707,805
20219103,191$698,340
20221,1373,446$704,175
20231,1353,498$692,221
20249893,188$631,314

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$27K$54K2015 Drug cost: $53,892 (USD; Tot_Drug_Cst)2016 Drug cost: $34,117 (USD; Tot_Drug_Cst)2017 Drug cost: $12,375 (USD; Tot_Drug_Cst)2018 Drug cost: $11,232 (USD; Tot_Drug_Cst)2019 Drug cost: $12,566 (USD; Tot_Drug_Cst)2020 Drug cost: $4,147 (USD; Tot_Drug_Cst)2021 Drug cost: $2,399 (USD; Tot_Drug_Cst)2022 Drug cost: $832 (USD; Tot_Drug_Cst)2023 Drug cost: $2,114 (USD; Tot_Drug_Cst)2024 Drug cost: $1,557 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015166401$53,892
2016147357$34,117
201775122$12,375
201870119$11,232
201957100$12,566
20203352$4,147
20213444$2,399
202280108$832
2023102137$2,114
202495132$1,557

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
66982Complex removal of cataract with insertion of prosthetic lens6993$517
66984Removal of cataract with insertion of prosthetic lens5911,058$372
66821Removal of recurring cataract in lens capsule using a laser189256$225
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more209209$104
92136Measurement of corneal curvature and depth of eye7251,219$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bacitracin-PolymyxinBacitracin/Polymyxin B Sulfate42491$617
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha11148$140
AcetazolamideAcetazolamide5263$104

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$141Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kuumba K. Long, MD?

Tedicare shows public-source Medicare data for Kuumba K. Long, MD (NPI 1558400291), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kuumba K. Long, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kuumba K. Long, MD?

Kuumba K. Long, MD is linked to MIDWEST EYE CONSULTANTS, P.C. (billing NPI 1801002522) in the available physician profile data.

Does Kuumba K. Long, MD have Open Payments data?

Kuumba K. Long, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.